Kenvue Inc. (NYSE:KVUE) Given Average Rating of “Hold” by Analysts

Shares of Kenvue Inc. (NYSE:KVUE) have been given an average rating of “Hold” by the twelve analysts that are covering the firm, MarketBeat.com reports. Seven equities research analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12-month price objective among brokerages that have covered the stock in the last year is $25.33.

Several equities analysts have recently weighed in on KVUE shares. Redburn Atlantic started coverage on Kenvue in a research report on Thursday, April 10th. They issued a “neutral” rating and a $23.50 price target for the company. Evercore ISI started coverage on Kenvue in a research report on Monday, March 24th. They issued an “in-line” rating and a $25.00 price target for the company. Royal Bank of Canada reiterated a “sector perform” rating and issued a $24.00 price target on shares of Kenvue in a research report on Monday, February 3rd. Piper Sandler boosted their target price on Kenvue from $24.00 to $27.00 and gave the stock an “overweight” rating in a research report on Monday, February 24th. Finally, Citigroup upped their target price on Kenvue from $22.00 to $24.50 and gave the stock a “neutral” rating in a research note on Friday, May 9th.

Kenvue Price Performance

Shares of NYSE KVUE opened at $23.86 on Friday. The stock has a market cap of $45.78 billion, a PE ratio of 45.02, a price-to-earnings-growth ratio of 2.62 and a beta of 1.02. Kenvue has a fifty-two week low of $17.67 and a fifty-two week high of $25.17. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.69 and a current ratio of 1.00. The stock has a fifty day moving average of $23.27 and a 200-day moving average of $22.64.

Kenvue (NYSE:KVUE) last announced its quarterly earnings results on Thursday, May 8th. The company reported $0.24 earnings per share for the quarter, beating the consensus estimate of $0.23 by $0.01. The company had revenue of $3.74 billion during the quarter, compared to analysts’ expectations of $3.69 billion. Kenvue had a return on equity of 20.97% and a net margin of 6.66%. The firm’s quarterly revenue was down 3.9% compared to the same quarter last year. During the same period in the previous year, the business earned $0.28 earnings per share. Equities research analysts anticipate that Kenvue will post 1.14 earnings per share for the current year.

Kenvue Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, May 28th. Shareholders of record on Wednesday, May 14th were paid a $0.205 dividend. The ex-dividend date of this dividend was Wednesday, May 14th. This represents a $0.82 dividend on an annualized basis and a yield of 3.44%. Kenvue’s dividend payout ratio is currently 149.09%.

Hedge Funds Weigh In On Kenvue

Several institutional investors have recently modified their holdings of the company. Evergreen Wealth Solutions LLC increased its position in shares of Kenvue by 2.6% during the 1st quarter. Evergreen Wealth Solutions LLC now owns 16,769 shares of the company’s stock valued at $402,000 after purchasing an additional 432 shares during the last quarter. Fulton Bank N.A. increased its position in shares of Kenvue by 0.6% during the 1st quarter. Fulton Bank N.A. now owns 78,888 shares of the company’s stock valued at $1,892,000 after purchasing an additional 465 shares during the last quarter. Scott & Selber Inc. increased its position in shares of Kenvue by 0.4% during the 1st quarter. Scott & Selber Inc. now owns 106,621 shares of the company’s stock valued at $2,557,000 after purchasing an additional 475 shares during the last quarter. Wealth Alliance LLC increased its position in shares of Kenvue by 1.6% during the 1st quarter. Wealth Alliance LLC now owns 31,778 shares of the company’s stock valued at $762,000 after purchasing an additional 486 shares during the last quarter. Finally, Principle Wealth Partners LLC increased its position in shares of Kenvue by 3.7% during the 4th quarter. Principle Wealth Partners LLC now owns 14,194 shares of the company’s stock valued at $303,000 after purchasing an additional 500 shares during the last quarter. 97.64% of the stock is currently owned by institutional investors.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.